BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29312903)

  • 1. Clinical Impact of Genomic Information in Pediatric Leukemia.
    Lalonde E; Wertheim G; Li MM
    Front Pediatr; 2017; 5():263. PubMed ID: 29312903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities.
    Tran TH; Hunger SP
    Semin Cancer Biol; 2022 Sep; 84():144-152. PubMed ID: 33197607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetics analysis as the central point of genetic testing in acute myeloid leukemia (AML): a laboratory perspective for clinical applications.
    Rosli AA; Azlan A; Rajasegaran Y; Mot YY; Heidenreich O; Yusoff NM; Moses EJ
    Clin Exp Med; 2023 Aug; 23(4):1137-1159. PubMed ID: 36229751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Acute Myeloid Leukemia Genomics, Where Do We Stand in 2018?
    Madanat YF; Kalaycio ME; Nazha A
    Acta Med Acad; 2019 Apr; 48(1):35-44. PubMed ID: 31264431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-Generation Sequencing in Acute Lymphoblastic Leukemia.
    Coccaro N; Anelli L; Zagaria A; Specchia G; Albano F
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31208040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencing.
    Kohlmann A; Bacher U; Schnittger S; Haferlach T
    Leuk Lymphoma; 2014 Aug; 55(8):1725-34. PubMed ID: 24144312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute myeloid leukemia in the era of precision medicine: recent advances in diagnostic classification and risk stratification.
    Kansal R
    Cancer Biol Med; 2016 Mar; 13(1):41-54. PubMed ID: 27144061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Utility of Next-Generation Sequencing in Acute Myeloid Leukemia.
    Yang F; Anekpuritanang T; Press RD
    Mol Diagn Ther; 2020 Feb; 24(1):1-13. PubMed ID: 31848884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating genomics into prognostic models for AML.
    Sanchez M; Levine RL; Rampal R
    Semin Hematol; 2014 Oct; 51(4):298-305. PubMed ID: 25311742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of Next-Generation Sequencing in Diagnosing and Minimal Residual Disease Detection in Patients With Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia.
    Sherali N; Hamadneh T; Aftab S; Alfonso M; Tsouklidis N
    Cureus; 2020 Sep; 12(9):e10696. PubMed ID: 33133861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multimodal genomics approach to diagnostic evaluation of pediatric hematologic malignancies.
    Hiemenz MC; Oberley MJ; Doan A; Aye L; Ji J; Schmidt RJ; Biegel JA; Bhojwani D; Raca G
    Cancer Genet; 2021 Jun; 254-255():25-33. PubMed ID: 33571894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based review of genomic aberrations in B-lymphoblastic leukemia/lymphoma: Report from the cancer genomics consortium working group for lymphoblastic leukemia.
    Akkari YMN; Bruyere H; Hagelstrom RT; Kanagal-Shamanna R; Liu J; Luo M; Mikhail FM; Pitel BA; Raca G; Shago M; Shao L; Smith LR; Smolarek TA; Yenamandra A; Baughn LB
    Cancer Genet; 2020 May; 243():52-72. PubMed ID: 32302940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative Genomic Analysis of Pediatric Myeloid-Related Acute Leukemias Identifies Novel Subtypes and Prognostic Indicators.
    Fornerod M; Ma J; Noort S; Liu Y; Walsh MP; Shi L; Nance S; Liu Y; Wang Y; Song G; Lamprecht T; Easton J; Mulder HL; Yergeau D; Myers J; Kamens JL; Obeng EA; Pigazzi M; Jarosova M; Kelaidi C; Polychronopoulou S; Lamba JK; Baker SD; Rubnitz JE; Reinhardt D; van den Heuvel-Eibrink MM; Locatelli F; Hasle H; Klco JM; Downing JR; Zhang J; Pounds S; Zwaan CM; Gruber TA; ; ; ; ; ;
    Blood Cancer Discov; 2021 Nov; 2(6):586-599. PubMed ID: 34778799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in next-generation sequencing for relapsed pediatric acute lymphoblastic leukemia: current insights and future directions.
    Mohd Nippah NF; Abu N; Ab Mutalib NS; Alias H
    Front Genet; 2024; 15():1394523. PubMed ID: 38894724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Precision medicine and molecular target drugs in pediatric hematologic malignancies: acute lymphoblastic leukemia].
    Takita J
    Rinsho Ketsueki; 2020; 61(6):657-664. PubMed ID: 32624540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Genomic Era of Clinical Oncology: Integrated Genomic Analysis for Precision Cancer Care.
    Surrey LF; Luo M; Chang F; Li MM
    Cytogenet Genome Res; 2016; 150(3-4):162-175. PubMed ID: 28002823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of next-generation sequencing in acute myeloid leukemia.
    Llop M; Sargas C; Barragán E
    Curr Opin Oncol; 2022 Nov; 34(6):723-728. PubMed ID: 36102349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic tools in acute myeloid leukemia: From the bench to the bedside.
    White BS; DiPersio JF
    Cancer; 2014 Apr; 120(8):1134-44. PubMed ID: 24474533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [NGS-based multi-gene panel testing in hematological malignancies: diagnosis and prognostic prediction].
    Tanigawa T; Kataoka K
    Rinsho Ketsueki; 2022; 63(4):294-301. PubMed ID: 35491219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic characterization of pediatric acute myeloid leukemia using next-generation sequencing.
    Schuback HL; Arceci RJ; Meshinchi S
    Semin Hematol; 2013 Oct; 50(4):325-32. PubMed ID: 24246700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.